Indinavir approved for HIV infection.
D017277:Drug Approval; D016527:Drug Costs; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000191:economics / Q000627:therapeutic use*; D006801:Humans; D019469:Indinavir; D011725:Pyridines / Q000191:economics / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
D017320:HIV Protease Inhibitors; D011725:Pyridines; D019469:Indinavir